
The Mediterranean diet has already shown in many studies to reduce cancer risk and improve heart health. Now, a new study is connecting the diet to a reduced risk for age-related macular degeneration (AMD).
The Mediterranean diet has already shown in many studies to reduce cancer risk and improve heart health. Now, a new study is connecting the diet to a reduced risk for age-related macular degeneration (AMD).
Our eyes, just like the rest of our body, need proper nutrition to stay healthy and functioning at their best. Two very important eye nutrients are lutein (LOO-teen) and zeaxanthin (zee-ah-ZAN-thin), both types of carotenoids (kuh-RAH-teh-noids).
New research recently published online in JAMA Ophthalmology show that high intake of carotenoids, specifically lutein and zeaxanthin, reduce the risk of advanced age-related macular degeneration (AMD) progression.
When it comes to macular degeneration, getting a diagnosis and beginning treatment even a few months sooner can make a big difference in the amount and quality of vision that can be maintained.
New research published in the journal PLos One earlier this month has many sufferers of age-related macular degeneration (AMD) hopeful for the possibility of a new treatment.
Researchers in Japan began recruiting patients on August 1 for a pilot study to determine the possibility of using induced pluripotent stem cell (iPSC) therapy to treat wet-type age-related macular degeneration.